{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:35:58Z","timestamp":1790735758187,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/19173-5"],"award-info":[{"award-number":["2014\/19173-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/10542-3"],"award-info":[{"award-number":["2016\/10542-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/07689-8"],"award-info":[{"award-number":["2018\/07689-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vph.2023.107176","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T02:29:16Z","timestamp":1682562556000},"page":"107176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches"],"prefix":"10.1016","volume":"150","author":[{"given":"\u00c9rica M.F.","family":"Gotardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas F.S.","family":"Gushiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Chweih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia C.","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Conran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vph.2023.107176_bb0005","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.vph.2023.107176_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2017.00146","article-title":"Heme as a target for therapeutic interventions","volume":"8","author":"Immenschuh","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0015","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.vph.2023.107176_bb0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molmed.2016.01.004","article-title":"Heme: modulator of plasma systems in hemolytic diseases","volume":"22","author":"Roumenina","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000356836","article-title":"Intravascular hemolysis: a disease mechanism not to be ignored","volume":"132","author":"Conran","year":"2014","journal-title":"Acta Haematol."},{"key":"10.1016\/j.vph.2023.107176_bb0035","article-title":"Insights into the emergence of paroxysmal nocturnal hemoglobinuria","volume":"12","author":"Colden","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","article-title":"Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria","volume":"149","author":"Hill","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.vph.2023.107176_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2023.107176_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphys.2014.00415","article-title":"Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development","volume":"5","author":"Schaer","year":"2014","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.vph.2023.107176_bb0055","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijsu.2013.10.007","article-title":"Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages","volume":"11","author":"Chen","year":"2013","journal-title":"Int. J. Surg."},{"issue":"5","key":"10.1016\/j.vph.2023.107176_bb0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.vph.2023.107176_bb0065","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2020.01323","article-title":"Pro-inflammatory actions of Heme and other hemoglobin-derived DAMPs","volume":"11","author":"Bozza","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.vph.2023.107176_bb0070","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3324\/haematol.2019.239343","article-title":"Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance","volume":"105","author":"Conran","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.vph.2023.107176_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.10.005","article-title":"Heme and hemolysis in innate immunity: adding insult to injury","volume":"50","author":"Martins","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vph.2023.107176_bb0080","series-title":"Sickle Cell anemia: From Basic Science to Clinical Practice","first-page":"49","article-title":"Overview of sickle cell anemia pathophysiology","author":"Steinberg","year":"2016"},{"issue":"11","key":"10.1016\/j.vph.2023.107176_bb0085","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00277-021-04636-3","article-title":"Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients","volume":"100","author":"Chenou","year":"2021","journal-title":"Ann. Hematol."},{"issue":"13","key":"10.1016\/j.vph.2023.107176_bb0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2\u20133","key":"10.1016\/j.vph.2023.107176_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2023.107176_bb0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2014-12-616250","article-title":"Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea","volume":"126","author":"Almeida","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2023.107176_bb0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood.V51.4.769b.769b","article-title":"Oxidative hemolysis and erythrocyte phospholipids","volume":"51","author":"Jain","year":"1978","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/bi00648a036","article-title":"The oxidation of phenylhydrazine: superoxide and mechanism","volume":"15","author":"Misra","year":"1976","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.fct.2006.09.008","article-title":"Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats","volume":"45","author":"Luangaram","year":"2007","journal-title":"Food Chem. Toxicol.: Intern. J. Publ. Br. Indus. Biol. Res. Assoc."},{"key":"10.1016\/j.vph.2023.107176_bb0130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fimmu.2020.01684","article-title":"Hemopexin as an inhibitor of hemolysis-induced complement activation","volume":"11","author":"Poillerat","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.vph.2023.107176_bb0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ajh.25742","article-title":"Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy","volume":"95","author":"Roumenina","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.vph.2023.107176_bb0140","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2023.107176_bb0145","article-title":"Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease","author":"Menon","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.vph.2023.107176_bb0155","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1172\/JCI64578","article-title":"Extracellular hemin crisis triggers acute chest syndrome in sickle mice","volume":"123","author":"Ghosh","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2023.107176_bb0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fimmu.2018.00179","article-title":"Characterization of renal injury and inflammation in an experimental model of intravascular hemolysis","volume":"9","author":"Merle","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.vph.2023.107176_bb0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00011-016-0955-9","article-title":"Red cell DAMPs and inflammation","volume":"65","author":"Mendonca","year":"2016","journal-title":"Inflam. Res.: Off. J. Eur. Histam. Res. Soc. ... [et al.]"},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cld.2018.12.002","article-title":"The liver in sickle cell disease","volume":"23","author":"Theocharidou","year":"2019","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0175","first-page":"255","article-title":"Erythrocyte membrane protein damage by oxidation products of phenylhydrazine","volume":"35","author":"Chakrabarti","year":"1995","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.vph.2023.107176_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dib.2017.05.026","article-title":"Data demonstrating the anti-oxidant role of hemopexin in the heart","volume":"13","author":"Ingoglia","year":"2017","journal-title":"Data Brief"},{"issue":"4","key":"10.1016\/j.vph.2023.107176_bb0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajh.23623","article-title":"Haptoglobin testing in hemolysis: measurement and interpretation","volume":"89","author":"Shih","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.vph.2023.107176_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.freeradbiomed.2017.04.003","article-title":"Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress","volume":"108","author":"Ingoglia","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"17","key":"10.1016\/j.vph.2023.107176_bb0195","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1089\/ars.2012.4605","article-title":"Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000109414.78907.F9","article-title":"Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery","volume":"94","author":"Philippidis","year":"2004","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700442","article-title":"Ferric citrate supplementation reduces red-blood-cell aggregation and improves CD163+ macrophage-mediated hemoglobin metabolism in a rat model of high-fat-diet-induced obesity","volume":"62","author":"Chang","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"24","key":"10.1016\/j.vph.2023.107176_bb0210","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1182\/blood-2010-04-277319","article-title":"Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity","volume":"116","author":"Vallelian","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vph.2023.107176_bb0215","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","article-title":"Identification of the receptor scavenging hemopexin-heme complexes","volume":"106","author":"Hvidberg","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0220","first-page":"392","article-title":"Liver Iron quantification with MR imaging: a primer for radiologists, Radiographics\u202f: a review publication of the Radiological Society of North America","volume":"38","author":"Labranche","year":"2018","journal-title":"Inc"},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.2830420116","article-title":"Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major","volume":"42","author":"Brittenham","year":"1993","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.vph.2023.107176_bb0230","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3324\/haematol.2020.265462","article-title":"Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease","volume":"106","author":"El Hoss","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0235","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3324\/haematol.2021.279623","article-title":"A novel index to evaluate ineffective erythropoiesis in hematological diseases offers insights into sickle cell disease","volume":"107","author":"Brewin","year":"2022","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.vph.2023.107176_bb0240","first-page":"1579","article-title":"Hemolysis in the spleen drives erythrocyte turnover","volume":"136","author":"Klei","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vph.2023.107176_bb0245","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/17474086.2019.1627192","article-title":"Considering the spleen in sickle cell disease","volume":"12","author":"El Hoss","year":"2019","journal-title":"Expert. Rev. Hematol."},{"issue":"12","key":"10.1016\/j.vph.2023.107176_bb0250","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ajh.26703","article-title":"The significance of spleen size in children with sickle cell anemia","volume":"97","author":"Nardo-Marino","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"21","key":"10.1016\/j.vph.2023.107176_bb0255","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.4916.4916","article-title":"Phenotypic characterization the Townes sickle Mices","volume":"124","author":"Nguyen","year":"2014","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.vph.2023.107176_bb0260","doi-asserted-by":"crossref","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","article-title":"Hemolysis-induced lethality involves inflammasome activation by heme","volume":"111","author":"Dutra","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.vph.2023.107176_bb0265","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.1994.tb06147.x","article-title":"Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms","volume":"98","author":"Szekanecz","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.vph.2023.107176_bb0275","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.trsl.2009.02.007","article-title":"Role of endothelin-1 in acute lung injury","volume":"153","author":"Comellas","year":"2009","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bjhh.2015.10.004","article-title":"Hemolytic vascular inflammation: an update","volume":"38","author":"Conran","year":"2016","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"2","key":"10.1016\/j.vph.2023.107176_bb0285","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0290","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jcph.1297","article-title":"Pharmacoproteomics profiling of plasma from beta-thalassemia patients in response to hydroxyurea treatment","volume":"59","author":"Zohaib","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2023.107176_bb0295","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bjh.15996","article-title":"The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia","volume":"186","author":"Brewin","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.2011.08580.x","article-title":"Soluble CD163 levels in children with sickle cell disease","volume":"153","author":"Moller","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.vph.2023.107176_bb0305","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.4049\/jimmunol.1202479","article-title":"Cutting edge: nitric oxide inhibits the NLRP3 inflammasome","volume":"189","author":"Hernandez-Cuellar","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-alpha in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.vph.2023.107176_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/adt.2021.090","article-title":"Repurposing of hydroxyurea against COVID-19: a promising immunomodulatory role","volume":"20","author":"Ben Moftah","year":"2022","journal-title":"Assay Drug Develop. Technol."},{"issue":"7","key":"10.1016\/j.vph.2023.107176_bb0325","first-page":"7896","article-title":"Glutamine ameliorates intestinal ischemia-reperfusion injury in rats by activating the Nrf2\/are signaling pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0330","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01967621","article-title":"Evaluation of anti-inflammatory and analgesic properties of L-glutamine","volume":"11","author":"Jain","year":"1981","journal-title":"Agents Actions"},{"issue":"9","key":"10.1016\/j.vph.2023.107176_bb0335","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.vph.2023.107176_bb0340","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/jcm11030630","article-title":"Plasma-derived Hemopexin as a candidate therapeutic agent for acute Vaso-occlusion in sickle cell disease: preclinical evidence","volume":"11","author":"Gentinetta","year":"2022","journal-title":"J. Clin. Med."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:21:35Z","timestamp":1761528095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":68,"alternative-id":["S1537189123000368"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107176","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107176"}}